Investment Analysts’ updated eps estimates for Wednesday, September 16th:
Acumen Pharmaceuticals (NASDAQ:ABOS) had its buy rating reiterated by analysts at BTIG Research. They currently have a $8.00 target price on the stock.
accesso Technology Group (LON:ACSO) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 575 target price on the stock.
Affirm (NASDAQ:AFRM) had its market outperform rating reiterated by analysts at Citizens Jmp. The firm currently has a $85.00 target price on the stock.
Ambarella (NASDAQ:AMBA) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $120.00 target price on the stock.
Grupo Aval Acciones y Valores (NYSE:AVAL) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $5.00 price target on the stock, down from their previous price target of $5.50.
Bank of America Corporation began coverage on shares of Bandwidth (NASDAQ:BAND). They issued a neutral rating and a $60.00 target price on the stock.
Credicorp (NYSE:BAP) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $482.00 target price on the stock, up from their previous target price of $453.00.
Bath & Body Works (NYSE:BBWI) had its hold rating reiterated by analysts at Argus.
BTG (LON:BTG) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 166 price target on the stock.
Anheuser-Busch InBev SA/NV (NYSE:BUD) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating.
CBIZ (NYSE:CBZ) had its market perform rating reaffirmed by analysts at Barrington Research.
C&C Group (LON:CCR) had its buy rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 138 target price on the stock.
Seaport Research Partners started coverage on shares of Chipotle Mexican Grill (NYSE:CMG). They issued a neutral rating on the stock.
Cogent Biosciences (NASDAQ:COGT) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $55.00 price target on the stock.
Corteva (NYSE:CTVA) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $103.00 price target on the stock.
Seaport Research Partners initiated coverage on shares of Darden Restaurants (NYSE:DRI). The firm issued a buy rating and a $240.00 target price on the stock.
Seaport Research Partners began coverage on shares of Brinker International (NYSE:EAT). They issued a buy rating and a $230.00 target price on the stock.
e.l.f. Beauty (NYSE:ELF) had its buy rating reiterated by analysts at B. Riley Financial, Inc.. B. Riley Financial, Inc. currently has a $115.00 target price on the stock, up from their previous target price of $100.00.
Guggenheim initiated coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH). Guggenheim issued a buy rating and a $70.00 price target on the stock.
The Hartford Insurance Group (NYSE:HIG) was downgraded by analysts at Mizuho from an outperform rating to a neutral rating. Mizuho currently has $154.00 price target on the stock, down from their previous price target of $163.00.
Harmonic (NASDAQ:HLIT) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $20.00 price target on the stock.
H-power (LON:HPOW) had its speculative buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 25 target price on the stock.
Inspired Entertainment (NASDAQ:INSE) had its buy rating reiterated by analysts at BWS Financial. They currently have a $20.00 price target on the stock.
IP Group (LON:IPO) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 110 target price on the stock.
Jack Henry & Associates (NASDAQ:JKHY) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $178.00 price target on the stock.
Kistos (LON:KIST) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 360 price target on the stock.
McDonald’s (NYSE:MCD) had its buy rating reissued by analysts at BTIG Research. They currently have a $350.00 price target on the stock.
Mastercraft Boat (NASDAQ:MCFT) had its neutral rating reiterated by analysts at B. Riley Financial, Inc.. The firm currently has a $22.00 target price on the stock, down from their previous target price of $25.00.
Meta Platforms (NASDAQ:META) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $886.00 price target on the stock.
Morgan Advanced Materials (LON:MGAM) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 280 price target on the stock.
Moonpig Group (LON:MOON) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 300 price target on the stock.
Freedom Broker assumed coverage on shares of MP Materials (NYSE:MP). The firm issued a hold rating and a $57.00 price target on the stock.
Nektar Therapeutics (NASDAQ:NKTR) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $178.00 price target on the stock.
Nuvation Bio (NYSE:NUVB) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $11.00 target price on the stock.
Nuvation Bio (NYSE:NUVB) had its market outperform rating reaffirmed by analysts at Citizens Jmp. Citizens Jmp currently has a $10.00 price target on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $25.00 price target on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $23.00 price target on the stock.
OGE Energy (NYSE:OGE) had its buy rating reiterated by analysts at Argus.
ON (NYSE:ONON) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $60.00 target price on the stock.
O’Reilly Automotive (NASDAQ:ORLY) had its buy rating reissued by analysts at DA Davidson. They currently have a $106.00 price target on the stock.
Hovde Group initiated coverage on shares of Pinnacle Financial Partners (NYSE:PNFP). Hovde Group issued an outperform rating and a $125.00 price target on the stock.
Pollen Street Group (LON:POLN) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,320 price target on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. Needham & Company LLC currently has $9.00 target price on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $15.00 target price on the stock.
Stellantis (NYSE:STLA) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating.
Transdigm Group (NYSE:TDG) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $1,350.00 target price on the stock.
Trustpilot Group (LON:TRST) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 315 price target on the stock.
Trustpilot Group (LON:TRST) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 375 target price on the stock.
M Winkworth (LON:WINK) had its house stock rating reissued by analysts at Shore Capital Group Ltd.
Wickes Group (LON:WIX) had its sell rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 165 price target on the stock.
William Blair initiated coverage on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL). The firm issued an outperform rating on the stock.
Receive News & Ratings for Acumen Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acumen Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
